#3 · ML / AI methods
Graph and transformer models infer regulatory networks and disease-linked RNAs
The dominant thread is pairing a learned architecture with an external biological information source to rank candidates. TEA-GCN builds co-expression networks from public RNA-seq, and GlncDDR applies graph neural network embeddings of cancer expression to predict 1232 candidate DDR-associated lncRNAs. CASER integrates multi-omics features in semi-supervised tri-training to prioritize epigenetic regulator genes, while PSGRN uses self-training with synthetic gold standards on single-cell perturbation data. GRNPred pairs masked expression pretraining with fine-tuning for TF-target inference, and APMF combines random-walk sequences with transformer contrastive learning for disease-related miRNAs. Not every item shares an explicit prior; what is new is where explanatory leverage sits, in graph structure, expression embeddings, and multi-omics integration rather than split design. The available summaries do not establish held-out generalization, so transferability remains untested at this level.
Preprints
Structure, Not Sequence: Tracking and Validating Folding Mechanisms in ESMFold's Trunk with Sparse Autoencoders
Interprets ESMFold's folding trunk with sparse autoencoders, showing single vs pair representations divide labor and tracing concept features to fold quality…
Localizing predictive concepts encoded in neural representations via hierarchical testing
CUTTIE clusters neural network units into a tree and tests clusters top-down with conditional independence tests, controlling family-wise error to localize…
Co$^2$ODE: Conditionally Coarse-Grained Model Discovery for Rewiring in Biochemical Networks
Co$^2$ODE learns sparse neural or symbolic ODEs with a conditional mask and VAE closure for context-dependent rewiring in biochemical networks, applied to…
Topic history
| Date | Rank |
|---|---|
| #3 | |
| #1 | |
| #5 | |
| #2 | |
| #1 | |
| #5 | |
| #5 | |
| #5 | |
| #5 | |
| #2 | |
| #1 | |
| #5 | |
| #11 | |
| #8 | |
| #10 | |
| #13 |